ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,273,791 | -24.7% | 47,458 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,691,939 | -89.6% | 47,453 | -92.6% | 0.00% | -90.9% |
| Q1 2023 | $16,308,716 | -28.9% | 642,057 | +13.5% | 0.01% | -31.2% |
| Q4 2022 | $22,952,751 | +21.9% | 565,908 | -50.3% | 0.02% | +14.3% |
| Q3 2022 | $18,831,813 | -6.4% | 1,138,466 | +99.2% | 0.01% | 0.0% |
| Q2 2022 | $20,120,000 | -40.2% | 571,430 | -21.9% | 0.01% | -12.5% |
| Q1 2022 | $33,645,000 | -47.5% | 731,564 | -24.3% | 0.02% | -40.7% |
| Q4 2021 | $64,090,000 | +6.9% | 966,685 | +0.7% | 0.03% | +3.8% |
| Q3 2021 | $59,948,000 | -36.6% | 960,232 | -15.9% | 0.03% | -35.0% |
| Q2 2021 | $94,547,000 | +25.0% | 1,141,595 | +0.1% | 0.04% | +14.3% |
| Q1 2021 | $75,614,000 | -14.0% | 1,140,313 | -0.4% | 0.04% | -14.6% |
| Q4 2020 | $87,890,000 | +76.2% | 1,145,443 | -1.1% | 0.04% | +57.7% |
| Q3 2020 | $49,883,000 | +24.5% | 1,158,462 | +24.9% | 0.03% | +18.2% |
| Q2 2020 | $40,072,000 | – | 927,799 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |